NCT01036165View on ClinicalTrials.gov

A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

PHASE3CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Multiple Sclerosis
Interventions
DEVICE

RebiSmart™

The RebiSmart™ autoinjector contains Rebif® 132 mcg multidose cartridges for sc injection.

Trial Locations (1)

02370

EMD Serono, Inc., Rockland

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT01036165 - A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study | Biotech Hunter | Biotech Hunter